Researchers Identify New Pediatric Rare Disease: Neuro-Ocular DAGLA-Related Syndrome (NODRS)
source: pixabay.com

Researchers Identify New Pediatric Rare Disease: Neuro-Ocular DAGLA-Related Syndrome (NODRS)

More rare conditions are discovered as we learn more about the human body and genetics. For example, shares an article in Medical XPress, a research team from the University of…

Continue Reading Researchers Identify New Pediatric Rare Disease: Neuro-Ocular DAGLA-Related Syndrome (NODRS)

Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?

Verge Genomics, based in San Francisco is one of a series of biotechs that have entered into a new era using AI in drug discovery. The company is backed by…

Continue Reading Will This Novel Drug That Utilizes AI Succeed in Having an Impact on ALS When so Many Others Have Failed?
CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 2)
Photo courtesy of CureDuchenne

CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 2)

Before you read on, don't forget to check out Part 1 of our interview with Jennifer Wallace Valdes, PT. In Part 1, Jennifer discusses her background, what Duchenne muscular dystrophy (DMD) is,…

Continue Reading CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 2)
Evaluating ST-920 for Fabry Disease: An Interview with Sangamo’s Bettina Cockroft, MD, MBA
Photo courtesy of Sangamo

Evaluating ST-920 for Fabry Disease: An Interview with Sangamo’s Bettina Cockroft, MD, MBA

The European Society for Gene and Cell Therapy (ESGCT) recently held its Annual Congress from October 11-14, 2022. During the ESGCT Congress, various stakeholders discussed data, trends, and new research…

Continue Reading Evaluating ST-920 for Fabry Disease: An Interview with Sangamo’s Bettina Cockroft, MD, MBA
Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome
emrahozaras / Pixabay

Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome

According to a story from prnewswire.com, the pharma company Harmony Biosciences Holdings, Inc., has recently announced the release of data from its phase 2 clinical trial. This trial is evaluating…

Continue Reading Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome
CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 1)
Photo courtesy of CureDuchenne

CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 1)

Occupational therapy for individuals with Duchenne muscular dystrophy (DMD) requires a unique and specialized approach to maximize benefit and reduce harm. It is incredibly important that those performing occupational therapy…

Continue Reading CureDuchenne Has Launched a Certified Occupational Therapist Program: An Interview with Jennifer Wallace Valdes, PT (Pt. 1)
Morgan’s Story: Building and Sharing My Understanding of CDH and Pulmonary Hypertension
Photo courtesy of Morgan Nuchols

Morgan’s Story: Building and Sharing My Understanding of CDH and Pulmonary Hypertension

At 29 years old, Morgan Nuchols is living the fullest life that she can. She loves challenging herself by doing puzzles. But her favorite activity? Making birthday and holiday cards…

Continue Reading Morgan’s Story: Building and Sharing My Understanding of CDH and Pulmonary Hypertension